News for Defence Therapeutics Inc. (DTCFF)

Published at

Jun 10, 2024 9:20 AM

by marketscreener.com

mixed

mixed

Defence to Participate in 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024

Defence Therapeutics Inc. , , a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to announce its participation to the Society of...

DTC.CN DTCFF

Read more →
Published at

May 1, 2024 9:20 AM

by marketscreener.com

mixed

mixed

Pancreatic Cancer: Successful Trial Against Pancreatic Cancer with Defence Therapeutics' ARM-002 Anti-Cancer Vaccine

Defence Therapeutics Inc. , , a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce the successful completion of a...

DTC.CN DTCFF

Read more →
Published at

Apr 6, 2024 12:05 AM

by marketscreener.com

mixed

mixed

Defence Therapeutics Announces Warrant Terms Amendment

Defence Therapeutics Inc. , one of the leading Canadian biotechnology companies working in the field of immune-oncology, announces an amendment to the terms of 1,497,780 Class A Common share...

DTC.CN DTCFF

Read more →
Published at

Mar 26, 2024 1:31 PM

by marketscreener.com

mixed

mixed

ERFOLGE VON DEFENCE BEI SEINEM ACCUTOX®-ARM(TM)-VAKZIN ZUR KREBSBEKÄMPFUNG FÜHREN ZUR ENTWICKLUNG EINES WIRKUNGSVOLLEN ARM-002(TM)-KREBSIMPFSTOFFS DER ZWEITEN GENERATION

EQS-News: Defence Therapeutics Inc. / Key word: Miscellaneous ERFOLGE VON DEFENCE BEI SEINEM ACCUTOX®-ARM-VAKZIN ZUR KREBSBEKÄMPFUNG FÜHREN ZUR ENTWICKLUNG EINES...

DTC.CN EQS.DE DTCFF

Read more →
Published at

Mar 26, 2024 8:01 AM

by marketscreener.com

positive

positive

DEFENCE’S SUCCESSFUL RESULTS ON ITS ACCUTOX® ANTI-CANCER ARMTM VACCINE CREATES A POTENT SECOND-GENERATION ANTI-CANCER ARM-002TM VACCINE

EQS-News: Defence Therapeutics Inc. / Key word: Product Launch DEFENCE’S SUCCESSFUL RESULTS ON ITS ACCUTOX® ANTI-CANCER ARMTM VACCINE CREATES A POTENT SECOND-GENERATION...

DTCFF DTC.CN

Read more →
Published at

Mar 22, 2024 11:35 PM

by marketscreener.com

neutral

neutral

Defence Completes 2nd Tranche of Financing

Defence Therapeutics Inc. , , one of the leading Canadian biotechnology companies working in the field of immune-oncology, announces the closing of the 2nd tranche of its previously announced...

DTCFF DTC.CN

Read more →
Published at

Mar 4, 2024 9:20 AM

by marketscreener.com

positive

positive

Defence Therapeutics Awarded Broad U.S. Patent Covering Its Pioneering Cancer-Killing AccuTOX(R) Technology

Defence Therapeutics Inc. , a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce the granting of US patent no....

DTCFF DTC.CN

Read more →
Published at

Mar 1, 2024 12:05 AM

by marketscreener.com

positive

positive

Defence Announces Peer-Reviewed Publication on Accum-E7 Anti-Cancer Vaccine in Cancer Science Journal and Financing Update

Defence Therapeutics Inc. , one of the leading Canadian biotechnology companies working in the field of immune-oncology, is pleased to announce the publication of a peer-reviewed study on the...

DTCFF DTC.CN

Read more →
Published at

Jan 20, 2024 1:35 AM

by marketscreener.com

neutral

neutral

Defence Financing

Defence Therapeutics Inc. , one of the leading Canadian biotechnology companies working in the field of immune-oncology announces, further to its news release on January 12, 2024, an amendment on...

DTCFF DTC.CN

Read more →
Published at

Jan 13, 2024 1:20 AM

by marketscreener.com

positive

positive

Defence Begins Trading on the OTCQB and Arranges Financing

Defence Therapeutics Inc. , , one of the leading Canadian biotechnology companies working in the field of immune-oncology is pleased to announce that it arranges a financing, and its common shares...

DTCFF DTC.CN

Read more →
Published at

Jun 16, 2021 4:35 PM

by investorideas.com

mixed

mixed

CSE Reports Strong Listings Growth in May 2021 Including a Landmark IPO

Toronto, Ontario - June 16, 2021 (Newsfile Corp.) (Investorideas.com Newswire) The Canadian Securities Exchange ("CSE" or "the Exchange") today announced its ma...

VEGI.CN SUPR.V RYAH.CN RGDCF GMC.V FNI.CN CMND.CN ABETF WDGY.CN PODAF PODA.CN HECO.CN FOGCD DTCFF DBDIF AVBT.CN ALPA.CN

Read more →
Published at

Jun 16, 2021 2:35 PM

by marketscreener.com

mixed

mixed

CSE Reports Strong Listings Growth in May 2021 Including a Landmark IPO

The Canadian Securities Exchange today announced its market statistics for the month of May 2021. The month was highlighted by near-record growth in listings.May 2021 Statistics● Trading... | June 16, 2021

VEGI.CN SUPR.V RYAH.CN RGDCF GMC.V FNI.CN CMND.CN ABETF WDGY.CN PODAF PODA.CN HECO.CN FOGCD DTCFF DBDIF AVBT.CN ALPA.CN

Read more →